- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Sustainable Track Record
Swiss Pharmaceuticals & Biotech Sustainable Track Record
Results
2
0 new
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
2 companies
SKAN Group
Market Cap: CHF 1.7b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 73.40
7D
4.6%
1Y
-6.4%
Basilea Pharmaceutica
Market Cap: CHF 668.6m
Engages in the discovering, developing, and commercializing drugs for bacterial or fungal infections.
BSLN
CHF 54.50
7D
15.0%
1Y
29.8%